30 results
CORRESP
APLS
Apellis Pharmaceuticals Inc
20 Nov 23
Correspondence with SEC
12:00am
clinical trial costs, contract manufacturing costs, research and innovation costs, pre-clinical study costs, device development costs, and other
8-K
EX-99.1
wen97 dq3
31 Jul 23
Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results
8:03am